Barinthus Biotherapeutics GAAP EPS of -$0.36 beats by $0.09
Source: SeekingAlpha
2025-11-07 14:09:32 ET
More on Barinthus Biotherapeutics
- Barinthus Biotherapeutics to combine with Clywedog Therapeutics
- Seeking Alpha’s Quant Rating on Barinthus Biotherapeutics
- Historical earnings data for Barinthus Biotherapeutics
- Financial information for Barinthus Biotherapeutics
Read the full article on Seeking Alpha
For further details see:
Barinthus Biotherapeutics GAAP EPS of -$0.36 beats by $0.09
Barinthus Biotherapeutics plc American Depositary Shares
NASDAQ: BRNS
BRNS Trading
2.4% G/L:
$0.615 Last:
3,771 Volume:
$0.639 Open:
BRNS Latest News
December 10, 2025 08:00:00 am
Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
November 19, 2025 06:18:00 pm
Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights
November 12, 2025 01:55:00 pm
Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights
November 07, 2025 07:30:00 am
Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments
BRNS Stock Data
$28,989,551
36,461,505
0.3%
5
N/A
Biotechnology & Life Sciences
Healthcare
GB
Germantown
